Clinical trial
An Exploratory Study of Ixabepilone Administered as an Enteric Coated Formulation in Patients With Advanced Cancer.
NCT00309049 is registered in ClinicalTrials.gov with R-Pharm as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Exploratory Study of Ixabepilone Administered as an Enteric Coated Formulation in Patients With Advanced Cancer.
- Lead sponsor
- R-Pharm
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- April 30, 2006
- Completion date
- May 31, 2007
- Enrollment
- 30
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
cancer